Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice

International Journal of Cancer

Volumn 135, Issue 6, 2014, Pages 1297-1306

  Sasaki, Soichiro ^a,b   Baba, Tomohisa ^a   Shinagawa, Kei ^c   Matsushima, Kouji ^b,d   Mukaida, Naofumi ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

CCL3; CCR5; colorectal cancer; fibroblast; HB EGF

Indexed keywords

AZOXYMETHANE; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; COLLAGEN TYPE 1; DEXTRAN SULFATE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL INFILTRATION; CELL PROLIFERATION; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FIBROBLAST; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

CCL3; CCR5; COLORECTAL CANCER; FIBROBLAST; HB-EGF;

ADENOCARCINOMA; ANIMALS; CARCINOGENESIS; CHEMOKINE CCL3; COLITIS; COLONIC NEOPLASMS; FEMALE; FIBROBLASTS; MICE; MICE, INBRED BALB C; RECEPTORS, CCR5;

EID: 84904038824     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28779     Document Type: Article

References (48)

1. Dvorak HF,. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
2. Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45.
3. Fiocchi C,. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
4. Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56: 1237-40.
5. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
6. Okayasu I, Yamada M, Mikami T, et al. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 2002; 17: 1078-83.
7. Okayasu I, Ohkusa T, Kajiura K, et al. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996; 39: 87-92.
8. Takahashi M, Wakabayashi K,. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004; 95: 475-80.
9. Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-70.
10. Popivanova BK, Kostadinova FI, Furuichi K, et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res 2009; 69: 7884-92.
11. Servais C, Erez N,. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation. J Pathol 2013; 229: 198-207.
12. Koliaraki V, Roulis M, Kollias G,. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. J Clin Invest 2012; 122: 4231-42.
13. Neufert C, Becker C, Tureci O, et al. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J Clin Invest 2013; 123: 1428-43.
14. Ishida Y, Kimura A, Kondo T, et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 2007; 170: 843-54.
15. Wu Y, Li YY, Matsushima K, et al. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol 2008; 181: 6384-93.
16. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154-60.
17. Gao JL, Wynn TA, Chang Y, et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997; 185: 1959-68.
18. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995; 269: 1583-5.
19. Corbett TH, Griswold DP, Jr, Roberts BJ, et al. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 1975; 35: 2434-9.
20. Kitakata H, Nemoto-Sasaki Y, Takahashi Y, et al. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 2002; 62: 6682-7.
21. Murata T, Mizushima H, Chinen I, et al. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res 2011; 71: 6633-42.
22. Jain RK, Lahdenranta J, Fukumura D,. Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model. PLoS Med 2008; 5: e24.
23. Li Q, Wang W, Yamada T, et al. Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network. Am J Pathol 2011; 179: 1483-93.
24. Allen M, Louise Jones J,. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011; 223: 162-76,.
25. Noël A, Jost M, Maquoi E,. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008; 19: 52-60.
26. Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56: 559-64.
27. Zhang G, Vargo D, Budker V, et al. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Ther 1997; 8: 1763-72.
28. Zhang G, Budker V, Wolff JA,. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-7.
29. Mukaida N, Baba T,. Chemokines in tumor development and progression. Exp Cell Res 2012; 318: 95-102.
30. Mueller L, Goumas FA, Affeldt M, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 2007; 171: 1608-18.
31. Mishra P, Banerjee D, Ben-Baruch A,. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 2011; 89: 31-9.
32. Matsumoto K, Nakamura T,. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006; 119: 477-83.
33. Miyamoto S, Yagi H, Yotsumoto F, et al. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci 2006; 97: 341-7.
34. Raab G, Klagsbrun M,. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997; 1333: F179-F199.
35. Hynes NE, Lane HA,. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005; 5: 341-54.
36. Ito Y, Higashiyama S, Takeda T, et al. Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma. Int J Pancreatol 2001; 29: 47-52.
37. Ito Y, Takeda T, Higashiyama S, et al. Expression of heparin binding epidermal growth factor-like growth factor in hepatocellular carcinoma: an immunohistochemical study. Oncol Rep 2001; 8: 903-7.
38. Ito Y, Higashiyama S, Takeda T, et al. Bimodal expression of heparin-binding EGF-like growth factor in colonic neoplasms. Anticancer Res 2001; 21: 1391-4.
39. Murayama Y, Miyagawa J, Shinomura Y, et al. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer. Int J Cancer 2002; 98: 505-13.
40. Miyamoto S, Hirata M, Yamazaki A, et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 2004; 64: 5720-7.
41. Lee KS, Park JH, Lee S, et al. HB-EGF induces delayed STAT3 activation via NF-kappaB mediated IL-6 secretion in vascular smooth muscle cell. Biochim Biophys Acta 2007; 1773: 1637-44.
42. Rahman FB, Kadowaki Y, Ishihara S, et al. Fibroblast-derived HB-EGF promotes Cdx2 expression in esophageal squamous cells. Lab Invest 2010; 90: 1033-48.
43. Naugler WE, Karin M,. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008; 18: 19-26.
44. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-96.
45. Shaked H, Hofseth LJ, Chumanevich A, et al. Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci USA 2012; 109: 14007-12.
46. Ylisastigui L, Vizzavona J, Drakopoulou E, et al. Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages. AIDS 1998; 12: 977-84.
47. Westby M, van der Ryst E,. CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection. Antivir Chem Chemother 2005; 16: 339-54.
48. Chen W, Zhan P, De Clercq E, et al. Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors. Curr Pharm Des 2012; 18: 100-12.